SCHEMBL6830597

SCHEMBL6830597

CN(CC#CCC(=O)O)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 1/20 0.45
PPARG P37231 1/20 0.45
EGLN1 Q9GZT9 1/20 0.43
CA12 O43570 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
ALDH1A1 P00352 2/20 0.39
GLA P06280 1/20 0.39
TSHR P16473 1/20 0.39
NPSR1 Q6W5P4 2/20 0.36
KMT2A Q03164 5/20 0.36
MEN1 O00255 3/20 0.36
NLRP3 Q96P20 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CHRNB2 P17787 1/20 0.36
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6827371 0.83 PPARG (0.41) GRM5PPARGEGLN1CA12CA2
SCHEMBL14269510 0.79 GRM5 (0.49) GRM5PPARGEGLN1CA12CA2
SCHEMBL8331122 0.77 GRM5 (0.53) GRM5PPARGEGLN1CA12CA2
SCHEMBL22485593 0.75 GRM5 (0.51) GRM5PPARGEGLN1CA12CA2
SCHEMBL196635 0.72 KMT2A (0.49) CA12CA2CA9ALDH1A1GLA
SCHEMBL6929485 0.72 CA12 (0.47) GRM5PPARGCA12CA2CA9
SCHEMBL19583155 0.72 GRM5 (0.57) GRM5PPARGEGLN1CA12CA2
SCHEMBL11973878 0.71 KMT2A (0.47) CA12CA2CA9ALDH1A1GLA
SCHEMBL11973371 0.71 KMT2A (0.47) CA12CA2CA9ALDH1A1GLA
Ethane SCHEMBL7405342 0.71 KMT2A (0.47) CA12CA2CA9ALDH1A1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6743940-B2 MICROBIOCIDES CIBA SPECIALTY CHEMICALS CORPORATION 2004-06-01 US disclosed
US-20020115881-A1 4-aminobut-2-ynecarboxylic acid derivatives CIBA SPECIALTY CHEMICALS CORP. 2002-08-22 US disclosed
EP-1215198-A1 4-Aminobut-2-yne carboxylic acid derivatives and their use as antimicrobial agents Ciba SC Holding AG (CH) 2002-06-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020115881-A1 4-aminobut-2-ynecarboxylic acid derivatives DDC, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, NDC1 GRM5 3249/4885PPARG 1877/4885EGLN1 1460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.